Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
Ticker SymbolPACB
Company namePacific Biosciences of California Inc
IPO dateOct 27, 2010
CEOMr. Christian O. Henry
Number of employees575
Security typeOrdinary Share
Fiscal year-endOct 27
Address1305 O'brien Drive
CityMENLO PARK
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code94025
Phone16505218000
Websitehttps://www.pacb.com/
Ticker SymbolPACB
IPO dateOct 27, 2010
CEOMr. Christian O. Henry
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data